Article Text

FRI0080 Is fatigue in rheumatoid arthritis represented by the RADAI-5?
  1. J. Sautner1,2,
  2. B. Rintelen1,2,
  3. A. Maktari1,
  4. I. Andel1,
  5. T. Nothnagl1,2,
  6. B.F. Leeb1,2
  1. 12Nd Departement for Internal Medicine, Lower Austrian Center for Rheumatology, Lower Austrian State Hospital Weinviertel Stockerau
  2. 2Karl Landsteiner Institute for Clinical Rheumatology, Stockerau, Austria


Objectives Fatigue is a cardinal symptom in Rheumatoid arthritis (RA) patients. The Rheumatoid Arthritis Disease Activity Index comprising five questions (RADAI-5) (1) is a patient centred disease activity measurement tool (a questionnaire covering 5 questions) used in every day clinical routine that does not include any question addressing fatigue. It was of interest to investigate if the RADAI-5 is influenced by fatigue as such.

Methods 189 outclinic RA patients (74% female, mean age 63,6 years, mean disease duration 112 months) were asked to indicate the amount of fatigue during the last 7 days on an 11 point numerical rating scale (from 0 representing “no fatigue at all” to 10 representing “extreme fatigue”) and also to complete the RADAI-5 questionnaire. To correlate fatigue and the RADAI-5 Spearman’s rho and kappa were calculated.

Results The mean RADAI-5 amounted to 3.19 (95%CI 2.87 – 3.51) indicating mild to moderate disease activity. The mean fatigue reached 4.11 (95%CI 3.73 – 4.49). Correlation between fatigue and RADAI-5 was moderate with rho 0.584 (p<0.01). Every single of the five RADAI-5-questions is moderately correlated to fatigue (rho: 0.470 - 0.604) showing the best correlation for question 4 (“How do you describe your general health today?” ranging from 0 “very good” to 10 “very bad”).

Conclusions Fatigue is moderately correlated to the general RADAI-5 as well as to the single questions. The best correlation could be shown for question 4 addressing general health. This is in line with another investigation of our group showing a good correlation between fatigue and patient satisfaction with the course of the disease (PATSAT).

  1. Leeb BF, Haindl PM, Maktari A et al. J Rheumatol. 2008 Jul;35(7):1294-9;

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.